GLP-1 Formulations: Auto-Injectors vs Compounded Vials

Why formulation matters

You have found a GLP-1 medication that works for your metabolism. The active ingredient is the same. But the way you receive it, the preparation, and the out-of-pocket cost are very different depending on whether you get a branded auto-injector or a compounded vial.

This difference is not trivial. One is a single-click pen from a pharmaceutical manufacturer. The other is a vial you draw from with an insulin syringe. Both contain the same active ingredients. Neither is inherently “better,” but they require different skills and have different costs. Understanding the formulation you will use lets you make an informed decision about whether a GLP-1 program fits your life.

Branded auto-injectors: FDA-approved pens

Branded auto-injectors are single-use prefilled pens manufactured by major pharmaceutical companies. They deliver a preset dose. You do not calculate, measure, or draw anything. You click a button and inject.

Brand-name semaglutide options

Semaglutide prescribed for type 2 diabetes:

• Prefilled pen, available in 0.25mg/0.5mL, 0.5mg/0.5mL, 1mg/0.5mL, and 2mg/1.5mL
• Delivers a preset dose (you select the dose on the pen dial, but each click is a fixed increment)
• Single-use, disposable pen
• Prescribed for blood sugar management in people with type 2 diabetes

Semaglutide prescribed for weight management:

• Prefilled pen, doses available from 0.25mg to 2.4mg
• Each dose level has its own dedicated, single-use auto-injector (you do not adjust the dose on a dial)
• Standard escalation sequence: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg
• FDA-approved specifically for weight management in adults with obesity or overweight with weight-related conditions^[1]

Oral semaglutide tablets:

• Oral tablets in 3mg, 7mg, and 14mg strengths
• Taken once daily on an empty stomach, at least 30 minutes before food or drink
• No injection required, but requires fasting
• Contains semaglutide as the active ingredient, designed for absorption through oral mucosa

Brand-name tirzepatide options

Tirzepatide prescribed for type 2 diabetes:

• Prefilled KwikPen, available in doses 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg
• Each dose is a separate, single-use pen
• Standard escalation: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg
• For blood sugar management

Tirzepatide prescribed for weight management:

• Identical prefilled pens and doses as the diabetes formulation
• Same dosage options and escalation sequence
• FDA-approved for weight management^[2]

Features of all branded auto-injectors

Pre-measured doses: The pen delivers exactly what it is labeled to deliver. You cannot draw a partial dose or a different dose than the pen was manufactured to give.

No unit conversion required: You do not think in units. The dose is the dose. Your provider says “use the 0.5mg pen” or “use the 5mg dose,” and you inject.

Single-use: After injection, you discard the pen. No reusable components, no filling, no waste management beyond throwing it in the trash (or using a sharps container, depending on your state guidelines).

Storage requirements: Refrigerate between 36-46 degrees Fahrenheit until you begin using it. Once opened, the pen can be kept at room temperature (below 86 degrees Fahrenheit) for up to 30 days. After 30 days at room temperature, or after 28 days from first use (if refrigerated), the medication expires.^[1]

Available only through branded pharmacies: These are not available from compounding pharmacies. You must have a prescription for the specific branded product, and the pharmacy fills it as a branded medication at the manufacturer’s price.

Compounded injectable vials

Compounded vials are prepared by licensed US-based compounding pharmacies.^[3] The active ingredient is the same (semaglutide or tirzepatide), but the vial is not manufactured by the brand-name pharmaceutical company. It is compounded in a pharmacy.

The key difference: compounded vials require you to draw the correct volume into an insulin syringe based on the vial’s concentration. This requires understanding the concentration, the dose you need, and how to convert between milligrams and units on an insulin syringe.

Semaglutide compounded vials

Common concentrations:

• 2.5mg/mL (most common)
• 5mg/mL (less common, higher concentration)
• 2mg/mL and 4mg/mL (occasionally prepared, less standard)

Vial sizes: Typically 1mL, 2mL, or 5mL multi-dose vials. A 5mL vial at 2.5mg/mL contains a total of 12.5mg of medication across multiple doses.

Administration: Once weekly subcutaneous injection. You draw your dose from the vial using an insulin syringe (U-100 standard).

Unit calculation: Depends on your vial’s concentration. At 2.5mg/mL, a 0.25mg dose equals 0.1mL or 10 units on a U-100 syringe. At 5mg/mL, the same 0.25mg dose equals 0.05mL or 5 units. Your provider specifies the concentration you have received and the volume or units to draw.

Tirzepatide compounded vials

Common concentrations:

• 5mg/mL (standard)
• 10mg/mL (higher concentration, less common)

Vial sizes: Typically 1mL or 2mL multi-dose vials. A 2mL vial at 5mg/mL contains 10mg total.

Administration: Once weekly subcutaneous injection. You draw your dose from the vial using an insulin syringe.

Unit calculation: At 5mg/mL, a 2.5mg starting dose equals 0.5mL or 50 units on a U-100 syringe. At 10mg/mL, the same 2.5mg dose equals 0.25mL or 25 units. Your provider will provide a specific calculation based on your vial’s concentration.

Storage for compounded vials

Refrigeration: Most compounded vials ship refrigerated and should be stored between 36-46 degrees Fahrenheit.

Room temperature: Many can be kept at room temperature (below 77 degrees Fahrenheit) for 28 days once the vial is opened. Check your vial’s specific instructions.

Expiration: Depends on the preparation date and your pharmacy’s protocols. Multi-dose vials typically remain stable for 28 days after opening. Your pharmacy labels your vial with an expiration date.

Oral compounded semaglutide

Compounded semaglutide can also be prepared as an oral medication. Unlike the brand-name oral semaglutide tablet, which uses a patented formulation with an absorption enhancer, compounded oral semaglutide uses sodium N-[8-(2-hydroxybenzoyl)amino]caprylate, commonly abbreviated SNAC, as an absorption enhancer to allow the drug to cross the gut barrier.

Dosing: Typically ranges from 1mg to 5mg per dose, depending on the formulation and your provider’s prescription.

Frequency: Usually taken once daily, fasting, per your provider’s specific instructions.

Evidence: Compounded oral semaglutide is less studied for weight management than the brand-name oral tablet or the injectable forms. The active ingredient is the same, but the compounded formulation has not undergone the same clinical trials as the brand-name oral tablet. Your provider will determine whether oral compounded semaglutide is appropriate for your situation.

Unit conversion reference tables

If you are using a compounded vial, your provider will tell you the concentration and the dose you need. These tables are for reference only. Always follow your provider’s specific instructions for your vial’s concentration.

Semaglutide unit conversion (at 2.5mg/mL concentration)

Semaglutide unit conversion (at 5mg/mL concentration)

Tirzepatide unit conversion (at 5mg/mL concentration)

Tirzepatide unit conversion (at 10mg/mL concentration)

Important: These tables are for reference only. The units shown assume a U-100 insulin syringe (100 units = 1mL). Your vial’s concentration is printed on the label. Always verify your concentration and follow your provider’s dosing instructions.

Pen vs vial: the practical experience

The choice between a branded auto-injector pen and a compounded vial affects your weekly routine.

Branded auto-injector experience

Click, inject, done. You grab the pen, dial the dose (if adjustable), click the button, and it delivers. No math. No syringe. No drawing. No risk of drawing the wrong volume. No risk of air bubbles. The device does the work.

The trade-off is cost. Branded pens cost significantly more than compounded vials, both out-of-pocket and in terms of your insurance co-pay (if you have prescription coverage). Brand-name GLP-1 medications typically cost more than compounded alternatives.

Compounded vial experience

You receive a multi-dose vial. When it is time to inject, you:

1. Review your concentration and the dose you need (e.g., “this is 2.5mg/mL, draw 0.5mL”)
2. Pull the plunger of an insulin syringe back to the mark for your dose (e.g., 50 units)
3. Insert the needle into the vial’s rubber septum
4. Push the plunger in to inject air into the vial
5. Pull the plunger back, drawing the medication into the syringe
6. Remove the needle from the vial
7. Inject subcutaneously in your abdomen, thigh, or upper arm

The vial stays in your refrigerator, ready for the next week. After 28 days, you get a new one.

This requires a few more steps and a bit more familiarity with syringes than a pen. But most patients become comfortable with the vial routine within 2 to 3 uses. You are not doing anything complicated. You are measuring a specific volume and injecting it, the same way a diabetic draws insulin.

The trade-off is effort for cost savings. Compounded vials cost 60-70% less than branded pens.

What this means for your decision

If you are evaluating a GLP-1 program, the formulation affects both what you pay and what you do each week.

Branded auto-injectors are convenient but expensive. They work best if you have robust insurance coverage for weight-loss medications or if cost is not your primary concern.

Compounded vials require a bit more skill but cost significantly less. They work best if you value affordability and do not mind a few extra steps in your weekly injection routine.

Transformation Health uses compounded medications from licensed US-based compounding pharmacies. This approach keeps the program affordable, starting at $249 per month for semaglutide and $339 per month for tirzepatide. Your provider will review your health history and determine whether a GLP-1 medication is appropriate for you. If it is, your pharmacy will prepare your specific dose and concentration based on your provider’s prescription, and you will receive your first vial within a few days of approval.

Citations

[1] U.S. Food and Drug Administration. “Prescribing Information for semaglutide for chronic weight management.” https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf

[2] U.S. Food and Drug Administration. “Prescribing Information for tirzepatide for chronic weight management.” https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf

[3] U.S. Food and Drug Administration. “Registered Outsourcing Facilities.” https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities